Validity of retrospective disease activity assessment in systemic lupus erythematosus

Journal of Rheumatology

Volumn 23, Issue 5, 1996, Pages 846-849

  Arce Salinas, Alejandro ^a,b   Cardiel, Mario H ^a,c   Guzmán, Jaime ^a   Alcocer Varela, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b PEMEX   (Mexico)

^c Recipient Gustavo Baz Prada N ^*  (Mexico)

Author keywords

Clinical indices; Disease activity; LACC; Mex SLEDAi; SLEDAI; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0029893497     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kalunian KC: Definition, classification, and activity indices. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. Philadelphia: Lea & Febiger, 1993:58-63.
2. Liang MH, Socher SA, Roberts WN, Esdaile JM: Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;31:817-25.
3. Petri M, Howard D, Repke J: Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center Experience. Arthritis Rheum 1991;34:1538-45.
4. Petri M, Genovese M, Engle E, Hochberg M: Definition, incidence, and clinical description of flare in systemic lupus erythematosus: A prospective cohort study. Arthritis Rheum 1997;34:937-44.
5. Llorente I, Richaud-Patin Y, Fior R, et al: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994;37:1647-55.
6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in Systemic Lupus Erythematosus: Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
7. Guzmán J, Cardiel MH, Arce-Salinas A, Sánchez Guerrero J, Alarcón-Segovia D: Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992;19:1551-8.
8. Urowitz MB, Gladman DD, Tozman ECS, Goldsmith CH: The lupus activity criteria count. J Rheumatol 1984;11:783-7.
9. Liang MH, Socher SA, Larson MG, Schur PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
10. Lacaille D, Clarke AE, Bloch DA, Danoff D, Esdaile JM: The impact of disease activity, treatment, and disease severity on short-term costs of systemic lupus erythematosus. J Rheumatol 1994;21:448-53.
11. Nossent HC, Swaak TJG, Berden JHM, and the Dutch Working Party on Systemic Lupus Erythematosus: Systemic lupus erythematosus after renal transplantation: Patient and graft survival and disease activity. Ann Intern Med 1991;114:183-8.
12. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
13. Guzmán J, Cardiel MH, Arce-Salinas A, Alarcón-Segovia D: The contribution of resting heart rate and routine blood tests to the clinical assessment of disease activity in SLE. J Rheumatol 1994;21:1845-8.
14. Nossent JC: Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Semin Arthritis Rheum 1993;23:16-21.
15. Chang C, Urowitz MB, Gladman DD, et al: Impact of SLEDAI on survival with validation of a disease activity index (abstr). Arthritis Rheum 1988;(suppl 28)31:S56.
16. Issenberg DA, Bacon PA, Bombardier C, et al: Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol 1989;16:1395-6.